Corbus Pharmaceuticals Holdings Inc
F:337
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corbus Pharmaceuticals Holdings Inc
F:337
|
US |
|
Unibail-Rodamco-Westfield SE
F:UBLB
|
FR |
|
Shanghai Electric Group Co Ltd
OTC:SIELF
|
CN |
|
T
|
Talisker Resources Ltd
OTC:TSKFF
|
CA |
|
D
|
Deutsche Telekom AG
XMUN:DTE
|
DE |
|
G
|
Gibraltar Industries Inc
XMUN:GI2
|
US |
|
D
|
Deutsche Telekom AG
DUS:DTE
|
DE |
|
R
|
Realtech AG
XMUN:RTC
|
DE |
|
S
|
Siemens AG
XHAM:SIE
|
DE |
|
M
|
Murphy Usa Inc
F:1MU
|
US |
|
HAL Trust
AEX:HAL
|
MC |
|
London Stock Exchange Group PLC
F:LS4D
|
UK |
|
L
|
Linedata Services SA
F:LN4
|
FR |
|
L
|
Lanson BCC SA
LSE:0Q6P
|
FR |
Wall St Price Targets
Price Targets Summary
Corbus Pharmaceuticals Holdings Inc
According to Wall Street analysts, the average 1-year price target for
Corbus Pharmaceuticals Holdings Inc is 18.416 EUR with a low forecast of 13.677 EUR and a high forecast of 26.405 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Corbus Pharmaceuticals Holdings Inc's stock price target?
Price Target
18.416
EUR
According to Wall Street analysts, the average 1-year price target for
Corbus Pharmaceuticals Holdings Inc is 18.416 EUR with a low forecast of 13.677 EUR and a high forecast of 26.405 EUR.